Your browser doesn't support javascript.
loading
Myeloid-derived suppressor cells in pleural effusion as a diagnostic marker for early discrimination of pulmonary tuberculosis from pneumonia.
Kim, Eun Sun; Islam, Jahirul; Lee, Hee-Jae; Seong, Seung-Yong; Youn, Je-In; Kwon, Byoung Soo; Kim, Se Joong; Lee, Jae-Ho.
Affiliation
  • Kim ES; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
  • Islam J; Hospital Medicine Center, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Lee HJ; Wide River Institute of Immunology, Seoul National University College of Medicine, Hongcheon, Republic of Korea.
  • Seong SY; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Youn JI; Wide River Institute of Immunology, Seoul National University College of Medicine, Hongcheon, Republic of Korea.
  • Kwon BS; Wide River Institute of Immunology, Seoul National University College of Medicine, Hongcheon, Republic of Korea.
  • Kim SJ; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Lee JH; Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Shaperon Inc., Republic of Korea.
Front Immunol ; 15: 1390327, 2024.
Article de En | MEDLINE | ID: mdl-38742106
ABSTRACT

Introduction:

Tuberculous pleural effusion (TPE) stands as one of the primary forms of extrapulmonary tuberculosis (TB) and frequently manifests in regions with a high prevalence of TB, consequently being a notable cause of pleural effusion in such areas. However, the differentiation between TPE and parapneumonic pleural effusion (PPE) presents diagnostic complexities. This study aimed to evaluate the potential of myeloid-derived suppressor cells (MDSCs) in the pleural fluid as a potential diagnostic marker for distinguishing between TPE and PPE.

Methods:

Adult patients, aged 18 years or older, who presented to the emergency room of a tertiary referral hospital and received a first-time diagnosis of pleural effusion, were prospectively enrolled in the study. Various immune cell populations, including T cells, B cells, natural killer (NK) cells, and MDSCs, were analyzed in both pleural fluid and peripheral blood samples.

Results:

In pleural fluid, the frequency of lymphocytes, including T, B, and NK cells, was notably higher in TPE compared to PPE. Conversely, the frequency of polymorphonuclear (PMN)-MDSCs was significantly higher in PPE. Notably, compared to traditional markers such as the neutrophil-to-lymphocyte ratio and adenosine deaminase level, the frequency of PMN-MDSCs emerged as a more effective discriminator between PPE and TPE. PMN-MDSCs demonstrated superior positive and negative predictive values and exhibited a higher area under the curve in the receiver operating characteristic curve analysis. PMN-MDSCs in pleural effusion increased the levels of reactive oxygen species and suppressed the production of interferon-gamma from T cells following nonspecific stimulation. These findings suggest that MDSC-mediated immune suppression may contribute to the pathology of both TPE and PPE.

Discussion:

The frequency of PMN-MDSCs in pleural fluid is a clinically useful indicator for distinguishing between TPE and PPE.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Épanchement pleural / Tuberculose pulmonaire / Marqueurs biologiques / Cellules myéloïdes suppressives Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Front Immunol / Front. immunol / Frontiers in immunology Année: 2024 Type de document: Article Pays de publication: Suisse

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Épanchement pleural / Tuberculose pulmonaire / Marqueurs biologiques / Cellules myéloïdes suppressives Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Front Immunol / Front. immunol / Frontiers in immunology Année: 2024 Type de document: Article Pays de publication: Suisse